Global Lab Automation Market
Description
MARKET SCOPE:
The global lab automation market is projected to grow significantly, registering a CAGR of 6.8% during the forecast period (2026 – 2034).
The growth of the global lab automation market is mainly driven by the increasing use of advanced technologies in laboratory workflows. Robotics, artificial intelligence (AI), machine learning (ML), and the Internet of Things (IoT) enhance workflows from traditional labs by enabling high-throughput screening, robotic liquid handling, and continuous instrument connectivity. These advancements improve efficiency, accuracy, and reproducibility in lab operations. The increasing demand for automation in pharmaceutical development, diagnostics, genomics, and personalized medicine has also expanded the lab automation market, as labs need faster turnaround times and lower human error. The use modular systems and high-throughput robotic platforms are improving sample preparation, data analysis, and workflow optimization; solidifying the notion that lab automation is here to stay.
Additionally, increased R&D in biotechnology, pharmaceuticals and life sciences is now a key driver of lab automation demand. The growing rates of chronic conditions along with precision medicine, is resulting in pressures on labs to adopt lab automation to create efficiencies in drug discovery and diagnostics. In addition, many organizations need automated systems to ensure they are compliant with highly regulated requirements for traceability, data integrity and compliance with GLP, ISO, FDA etc. The pandemic has exacerbated current operational pressures (consistent with trend), namely increasing pressure on HR driven by labor shortages, increased operational costs, the need to enhance workflows etc. which has resulted in the emergence of lab automation as innovation welcomed by organizations to streamline processes for compliance and efficiency across the global healthcare and life sciences ecosystem.
MARKET OVERVIEW:
Driver: Rising Demand for High-Throughput Screening and Operational Efficiency
The increasing demand for high-throughput screening (HTS) in pharmaceutical, biotechnology and diagnostics laboratories is a significant driver of the global lab automation market. Drug discovery and clinical testing often require the processing of millions of samples quickly, and the traditional methods of manual processes cannot hold pace with industry timelines. Automated processes have been employed, such as robotic liquid handlers, integrated laboratory instrumentation platforms and workflow oriented, AI-enabled data management software. Automating repetitive laboratory workflows improves reproducibility, reduces human errors and improves accuracy. This change alone improves the overall cost per test lower, in addition to producing faster research and development cycles. Conclusion, laboratory automation lowers costs through efficiencies of manual methods. Further to this are growing applications in personal medicine and genomics that are changing to even larger volumes of complex data with increasingly faster metrics.
Restraint: High Capital Investment and Maintenance Costs Limiting Adoption
Although there are advantages to laboratory automation, the high upfront cost of implementation is one of the main barriers to lab automation market expansion. Specialty robotic systems, automated storage, and AI-based workflow technologies require substantial capital investment which diminishes its appeal to small and mid-sized labs that are unable to invest significant amounts for lab automation equipment and technology. In addition, ongoing costs such as system calibration, software upgrades, operator training, and technical support further inhibit the investment potential. Smaller research facilities, many in developing countries, may have lower test volumes and limited infrastructure which makes them less inclined to justify investment in lab automation. In addition, there is skills shortage in this space as many laboratories are challenged with maintaining unusually complex automated systems. There will need to be an effort to provide affordable, adaptable and scalable automation solutions if the market can be fully penetrated. Ultimately, the value proposition will be restricted to larger organizations or well-funded research institutes.
Opportunity: Integration of Artificial Intelligence and Advanced Data Analytics
The lab automation market recognizes significant potential in using artificial intelligence, machine learning, and big data analytics across laboratory workflows. Advanced new technologies have opened the door to predictive insights, real-time error detection, and better use of resources. For example, new AI algorithms, will forecast reagent usage, identify the existence of anomalous readings in experimental results, or even suggest alternative approaches to testing - this is enabling smarter and faster research. Areas like genomics, precision oncology medicine, and clinical diagnostics will experience significant impacts, as there are large datasets and information to manage and exhibit at scale. Vendors that create AI-driven automation applications will lead the market by providing laboratories with applications that not only automate their tasks but support and assist in making scientific decisions. The world of laboratories is increasingly embracing a data-driven approach; the convergence, fusion, and integration of AI and automation will present a significant growth opportunity that could shift and change how research, innovative solutions, and data accuracy is viewed in science.
SEGMENTATION ANALYSIS:
The Modular Automation Systems Segment is anticipated to grow significantly during the forecast period
The modular automation systems segment in the lab automation market is expected to dominate during the forecast period primarily because of their flexibility, scalability, and cost-savings potential. Modular automation systems give laboratories the ability to automate a specific process, such as liquid handling, sample storage, or data management, without needing to replace an entire laboratory workflow. The modular design provides opportunities for customization and integration, making modular automation highly applicable for small and mid-sized laboratories, academic research laboratories, and budget-constrained biotechnology companies. Additionally, the ability to upgrade and expand these systems as needs grow also supports further adoption of modular automation, thus making modular automation the preferable approach for diverse laboratory settings.
REGIONAL ANALYSIS:
The North America region is set to witness significant growth during the forecast period
The North America lab automation market will continue to be the largest and leading market over the forecast period. The growth will primarily be attributed to high-tech healthcare infrastructure, the presence of leading pharmaceutical and biotechnology companies with notable market share, and high investment levels in the area of research and development. Apart from this, the region has strong market shares in the lab automation area, with the majority of sales stemming from the US and Canada. This is because both the U.S. and Canada have experienced early adoption of laboratory automation through robotics, AI, and data-driven systems that lead to increased efficiency of laboratory testing in a timely manner. There are also some rising trends that will further spur the market including the growing incidence rate of chronic diseases in North America (e.g. obesity, diabetes), increasing demand for personalized medicine and therapy, the growing need for high-throughput clinical testing, and increased volumes of routine testing in the lab automation market. These trends create a huge incentive for laboratories to start using labor automation systems exclusively. Moreover, regulatory frameworks such as FDA and CLIA for compliance, traceability, and data integrity has an ancillary impact on automation adoption. Thus, the North America region will continue to lead in lab automation.
COMPETITIVE ANALYSIS:
The global lab automation market is reasonably competitive with mergers, acquisitions, and Product launches. See some of the major key players in the market.
Specimen Handling Systems
Dissolution Testing Systems
Sample Transport Systems
Automated Liquid Handling Systems
Robotic Systems
Storage Retrieval Systems
Others
Total Automation Systems
Devices
Accessories
Drug Discovery & Development
Others
Pharmaceutical & Biotechnology Companies
Others
Europe (Germany, UK, France, Spain, Italy and Rest of Europe)
Asia-Pacific (China, Japan, India, South Korea, Australia and Rest of Asia-Pacific)
Latin America (Brazil, Mexico, Argentina and Rest of Latin America)
Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa and Rest of Middle East and Africa)
KEY REASONS TO PURCHASE THIS REPORT:
The global lab automation market is projected to grow significantly, registering a CAGR of 6.8% during the forecast period (2026 – 2034).
The growth of the global lab automation market is mainly driven by the increasing use of advanced technologies in laboratory workflows. Robotics, artificial intelligence (AI), machine learning (ML), and the Internet of Things (IoT) enhance workflows from traditional labs by enabling high-throughput screening, robotic liquid handling, and continuous instrument connectivity. These advancements improve efficiency, accuracy, and reproducibility in lab operations. The increasing demand for automation in pharmaceutical development, diagnostics, genomics, and personalized medicine has also expanded the lab automation market, as labs need faster turnaround times and lower human error. The use modular systems and high-throughput robotic platforms are improving sample preparation, data analysis, and workflow optimization; solidifying the notion that lab automation is here to stay.
Additionally, increased R&D in biotechnology, pharmaceuticals and life sciences is now a key driver of lab automation demand. The growing rates of chronic conditions along with precision medicine, is resulting in pressures on labs to adopt lab automation to create efficiencies in drug discovery and diagnostics. In addition, many organizations need automated systems to ensure they are compliant with highly regulated requirements for traceability, data integrity and compliance with GLP, ISO, FDA etc. The pandemic has exacerbated current operational pressures (consistent with trend), namely increasing pressure on HR driven by labor shortages, increased operational costs, the need to enhance workflows etc. which has resulted in the emergence of lab automation as innovation welcomed by organizations to streamline processes for compliance and efficiency across the global healthcare and life sciences ecosystem.
MARKET OVERVIEW:
Driver: Rising Demand for High-Throughput Screening and Operational Efficiency
The increasing demand for high-throughput screening (HTS) in pharmaceutical, biotechnology and diagnostics laboratories is a significant driver of the global lab automation market. Drug discovery and clinical testing often require the processing of millions of samples quickly, and the traditional methods of manual processes cannot hold pace with industry timelines. Automated processes have been employed, such as robotic liquid handlers, integrated laboratory instrumentation platforms and workflow oriented, AI-enabled data management software. Automating repetitive laboratory workflows improves reproducibility, reduces human errors and improves accuracy. This change alone improves the overall cost per test lower, in addition to producing faster research and development cycles. Conclusion, laboratory automation lowers costs through efficiencies of manual methods. Further to this are growing applications in personal medicine and genomics that are changing to even larger volumes of complex data with increasingly faster metrics.
Restraint: High Capital Investment and Maintenance Costs Limiting Adoption
Although there are advantages to laboratory automation, the high upfront cost of implementation is one of the main barriers to lab automation market expansion. Specialty robotic systems, automated storage, and AI-based workflow technologies require substantial capital investment which diminishes its appeal to small and mid-sized labs that are unable to invest significant amounts for lab automation equipment and technology. In addition, ongoing costs such as system calibration, software upgrades, operator training, and technical support further inhibit the investment potential. Smaller research facilities, many in developing countries, may have lower test volumes and limited infrastructure which makes them less inclined to justify investment in lab automation. In addition, there is skills shortage in this space as many laboratories are challenged with maintaining unusually complex automated systems. There will need to be an effort to provide affordable, adaptable and scalable automation solutions if the market can be fully penetrated. Ultimately, the value proposition will be restricted to larger organizations or well-funded research institutes.
Opportunity: Integration of Artificial Intelligence and Advanced Data Analytics
The lab automation market recognizes significant potential in using artificial intelligence, machine learning, and big data analytics across laboratory workflows. Advanced new technologies have opened the door to predictive insights, real-time error detection, and better use of resources. For example, new AI algorithms, will forecast reagent usage, identify the existence of anomalous readings in experimental results, or even suggest alternative approaches to testing - this is enabling smarter and faster research. Areas like genomics, precision oncology medicine, and clinical diagnostics will experience significant impacts, as there are large datasets and information to manage and exhibit at scale. Vendors that create AI-driven automation applications will lead the market by providing laboratories with applications that not only automate their tasks but support and assist in making scientific decisions. The world of laboratories is increasingly embracing a data-driven approach; the convergence, fusion, and integration of AI and automation will present a significant growth opportunity that could shift and change how research, innovative solutions, and data accuracy is viewed in science.
SEGMENTATION ANALYSIS:
The Modular Automation Systems Segment is anticipated to grow significantly during the forecast period
The modular automation systems segment in the lab automation market is expected to dominate during the forecast period primarily because of their flexibility, scalability, and cost-savings potential. Modular automation systems give laboratories the ability to automate a specific process, such as liquid handling, sample storage, or data management, without needing to replace an entire laboratory workflow. The modular design provides opportunities for customization and integration, making modular automation highly applicable for small and mid-sized laboratories, academic research laboratories, and budget-constrained biotechnology companies. Additionally, the ability to upgrade and expand these systems as needs grow also supports further adoption of modular automation, thus making modular automation the preferable approach for diverse laboratory settings.
REGIONAL ANALYSIS:
The North America region is set to witness significant growth during the forecast period
The North America lab automation market will continue to be the largest and leading market over the forecast period. The growth will primarily be attributed to high-tech healthcare infrastructure, the presence of leading pharmaceutical and biotechnology companies with notable market share, and high investment levels in the area of research and development. Apart from this, the region has strong market shares in the lab automation area, with the majority of sales stemming from the US and Canada. This is because both the U.S. and Canada have experienced early adoption of laboratory automation through robotics, AI, and data-driven systems that lead to increased efficiency of laboratory testing in a timely manner. There are also some rising trends that will further spur the market including the growing incidence rate of chronic diseases in North America (e.g. obesity, diabetes), increasing demand for personalized medicine and therapy, the growing need for high-throughput clinical testing, and increased volumes of routine testing in the lab automation market. These trends create a huge incentive for laboratories to start using labor automation systems exclusively. Moreover, regulatory frameworks such as FDA and CLIA for compliance, traceability, and data integrity has an ancillary impact on automation adoption. Thus, the North America region will continue to lead in lab automation.
COMPETITIVE ANALYSIS:
The global lab automation market is reasonably competitive with mergers, acquisitions, and Product launches. See some of the major key players in the market.
- QIAGEN
- Agilent Technologies, Inc
- Thermo Fisher Scientific Inc
- Siemens Healthineers AG
- Danaher Corporation
- F. Hoffmann-La Roche Ltd
- Eppendorf SE
- Hudson Lab Automation
- BMG LABTECH GmbH
- Hamilton Company
- In June 2024, QIAGEN announced its 2028 growth strategy with the upcoming launch of QIAsymphony Connect in 2025 and QIASprint Connect in 2026, designed to meet mid- and high-throughput laboratory needs.
- In January 2025, Agilent Technologies launched its ADS 2 Advanced Dilution System, improving lab productivity by streamlining autodilution workflows in ICP-MS/OES applications.
- In April 2025, Siemens Healthineers announced the Atellica Integrated Automation system, which consolidates up to 25 manual tasks and reduces hands-on workload by 75%, enhancing lab throughput.
- By Type
Specimen Handling Systems
Dissolution Testing Systems
Sample Transport Systems
Automated Liquid Handling Systems
Robotic Systems
Storage Retrieval Systems
Others
- By Automation Type
Total Automation Systems
- By Product
Devices
Accessories
- By Application
Drug Discovery & Development
Others
- By End-User
Pharmaceutical & Biotechnology Companies
Others
- By Region
Europe (Germany, UK, France, Spain, Italy and Rest of Europe)
Asia-Pacific (China, Japan, India, South Korea, Australia and Rest of Asia-Pacific)
Latin America (Brazil, Mexico, Argentina and Rest of Latin America)
Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa and Rest of Middle East and Africa)
KEY REASONS TO PURCHASE THIS REPORT:
- It provides a technological development map over time to understand the industry’s growth rate and indicates how the lab automation market is evolving.
- The report offers a dynamic method to various factors that drive or restrain the growth of the market and specifies which lab automation submarket will be the main driver of the overall market from 2026 to 2034.
- It renders a definite analysis of changing competitive dynamics and stipulates the leading players and what are their prospects over the forecast period.
- It builds a nine-year estimate based on how the market is predicted to grow and shows what will market shares of the global region change by 2034 and which country will lead the market in 2034.
Table of Contents
163 Pages
- 1. Executive Summary
- 1.1. Market Snapshot
- 1.2. Global Lab Automation Market - Regional Analysis
- 1.3. Global Lab Automation Market - Segment Analysis
- 1.3.1. Global Lab Automation Market, By Type
- 1.3.2. Global Lab Automation Market, By Automation Type
- 1.3.3. Global Lab Automation Market, By Product
- 1.3.4. Global Lab Automation Market, By Application
- 1.3.5. Global Lab Automation Market, By End-User
- 2. Overview And Scope
- 2.1. Market Vision
- 2.1.1. Market Definition
- 2.2. Market Segmentation
- 3. Global Lab Automation Market Overview, By Region: 2020 Vs 2025 Vs 2034
- 3.1. Global Lab Automation Market, By Region (2020 VS 2025 VS 2034)
- 3.2. North Lab Automation Market, By Country (2020 VS 2025 VS 2034)
- 3.3. Europe Lab Automation Market, By Country (2020 VS 2025 VS 2034)
- 3.4. Asia-Pacific Lab Automation Market, By Country (2020 VS 2025 VS 2034)
- 3.5. Latin America Lab Automation Market, By Country (2020 VS 2025 VS 2034)
- 3.6. Middle East & Africa Lab Automation Market, By Country (2020 VS 2025 VS 2034)
- 4. Global Lab Automation Market Dynamics
- 4.1. Market Overview
- 4.1.1. Market Drivers
- 4.1.1.1. Market Driver 1
- 4.1.1.2. Market Drivers 2
- 4.1.2. Market Restraints/ Challenges Analysis
- 4.1.2.1. Market Restraints/ Challenges Analysis 1
- 4.1.2.2. Market Restraints/ Challenges Analysis 2
- 4.1.3. Market Opportunities
- 4.1.3.1. Market Opportunities 1
- 4.1.3.2. Market Opportunities 2
- 4.2. PESTLE Analysis
- 4.2.1. Political Factors
- 4.2.2. Economic Factors
- 4.2.3. Social Factors
- 4.2.4. Technological Factors
- 4.2.5. Legal Factors
- 4.2.6. Environmental Factors
- 4.3. Value Chain Analysis/Supply Chain Analysis
- 4.4. Porter’s Five Forces Model
- 4.4.1. Bargaining Power of Suppliers
- 4.4.2. Bargaining Power of Buyers
- 4.4.3. The threat of New Entrants
- 4.4.4. Threat of Substitutes
- 4.4.5. Intensity of Rivalry
- 4.5. Covid-19 Impact Analysis on Global Lab Automation Market
- ** In – depth qualitative analysis will be provided in the final report subject to market
- 5. Global Lab Automation Market, By Type
- 5.1. Overview
- 5.2. Global Lab Automation Market By Type (2020 - 2034) (USD Million)
- 5.3. Key Findings for Lab Automation Market - By Type
- 5.3.1. Plate Readers
- 5.3.2. Specimen Handling Systems
- 5.3.3. Dissolution Testing Systems
- 5.3.4. Sample Transport Systems
- 5.3.5. Automated Liquid Handling Systems
- 5.3.6. Robotic Systems
- 5.3.7. Storage Retrieval Systems
- 5.3.8. Others
- 6. Global Lab Automation Market, By Automation Type
- 6.1. Overview
- 6.2. Global Lab Automation Market By Automation Type (2020 - 2034) (USD Million)
- 6.3. Key Findings for Lab Automation Market - By Automation Type
- 6.3.1. Modular Automation Systems
- 6.3.2. Total Automation Systems
- 7. Global Lab Automation Market, By Product
- 7.1. Overview
- 7.2. Global Lab Automation Market By Product (2020 - 2034) (USD Million)
- 7.3. Key Findings for Lab Automation Market - By Product
- 7.3.1. Software
- 7.3.2. Devices
- 7.3.3. Accessories
- 8. Global Lab Automation Market, By Application
- 8.1. Overview
- 8.2. Global Lab Automation Market By Application (2020 - 2034) (USD Million)
- 8.3. Key Findings for Lab Automation Market - By Application
- 8.3.1. Diagnostics
- 8.3.2. Drug Discovery & Development
- 8.3.3. Others
- 9. Global Lab Automation Market, By End-User
- 9.1. Overview
- 9.2. Global Lab Automation Market By End-User (2020 - 2034) (USD Million)
- 9.3. Key Findings for Lab Automation Market - By End-User
- 9.3.1. Academic & Research Institutes
- 9.3.2. Pharmaceutical & Biotechnology Companies
- 9.3.3. Others
- 10. Global Lab Automation Market, By Region
- 10.1. Overview
- 10.2. Global Lab Automation Market, By Region (2020 - 2034) (USD Million)
- 10.3. Key Findings For Lab Automation Market- By Region
- 10.4. Global Lab Automation Market, By Type
- 10.5. Global Lab Automation Market, By Automation Type
- 10.6. Global Lab Automation Market, By Product
- 10.7. Global Lab Automation Market, By Application
- 10.8. Global Lab Automation Market, By End-User
- 11. Global Lab Automation Market- North America
- 11.1. Overview
- 11.2. North America Lab Automation Market (2020 - 2034) (USD Million)
- 11.3. North America Lab Automation Market, By Type
- 11.4. North America Lab Automation Market, By Automation Type
- 11.5. North America Lab Automation Market, By Product
- 11.6. North America Lab Automation Market, By Application
- 11.7. North America Lab Automation Market, By End-User
- 11.8. North America Lab Automation Market by Country
- 11.8.1. United States
- 11.8.2. Canada
- 12. Global Lab Automation Market- Europe
- 12.1. Overview
- 12.2. Europe Lab Automation Market (2020 - 2034) (USD Million)
- 12.3. Europe Lab Automation Market, By Type
- 12.4. Europe Lab Automation Market, By Automation Type
- 12.5. Europe Lab Automation Market, By Product
- 12.6. Europe Lab Automation Market, By Application
- 12.7. Europe Lab Automation Market, By End-User
- 12.8. Europe Lab Automation Market by Country
- 12.8.1. Germany
- 12.8.2. UK
- 12.8.3. France
- 12.8.4. Spain
- 12.8.5. Italy
- 12.8.6. Rest of Europe
- 13. Global Lab Automation Market - Asia-Pacific
- 13.1. Overview
- 13.2. Asia-Pacific Lab Automation Market (2020 - 2034) (USD Million)
- 13.3. Asia-Pacific Lab Automation Market, By Type
- 13.4. Asia-Pacific Lab Automation Market, By Automation Type
- 13.5. Asia-Pacific Lab Automation Market, By Product
- 13.6. Asia-Pacific Lab Automation Market, By Application
- 13.7. Asia-Pacific Lab Automation Market, By End-User
- 13.8. Asia-Pacific Lab Automation Market by Country
- 13.8.1. China
- 13.8.2. Japan
- 13.8.3. India
- 13.8.4. South Korea
- 13.8.5. Australia
- 13.8.6. Rest of Asia-Pacific
- 14. Global Lab Automation Market- Latin America
- 14.1. Overview
- 14.2. Latin America Lab Automation Market (2020 - 2034) (USD Million)
- 14.3. Latin America Lab Automation Market, By Type
- 14.4. Latin America Lab Automation Market, By Automation Type
- 14.5. Latin America Lab Automation Market, By Product
- 14.6. Latin America Lab Automation Market, By Application
- 14.7. Latin America Lab Automation Market, By End-User
- 14.8. Latin America Lab Automation Market by Country
- 14.8.1. Brazil
- 14.8.2. Mexico
- 14.8.3. Argentina
- 14.8.4. Rest Of Latin America
- 15. Global Lab Automation Market- Middle East & Africa
- 15.1. Overview
- 15.2. Middle East & Africa Lab Automation Market Size (2020 - 2034) (USD Million)
- 15.3. Middle East & Africa Lab Automation Market, By Type
- 15.4. Middle East & Africa Lab Automation Market, By Automation Type
- 15.5. Middle East & Africa Lab Automation Market, By Product
- 15.6. Middle East & Africa Lab Automation Market, By Application
- 15.7. Middle East & Africa Lab Automation Market, By End-User
- 15.8. Middle East & Africa Lab Automation Market, By Country
- 15.8.1. Saudi Arabia
- 15.8.2. UAE
- 15.8.3. Israel
- 15.8.4. South Africa
- 15.8.5. Rest of Middle East & Africa
- 16. Global Lab Automation Market- Competitive Landscape
- 16.1. Key Competitive Analysis
- 16.2. Key Strategies Adopted by the Leading Players
- 16.3. Global Lab Automation Market Competitive Positioning
- 16.3.1. Important Performers
- 16.3.2. Emerging Innovators
- 16.3.3. Market Players with Moderate Innovation
- 17. Global Lab Automation Market- Company Profiles
- 17.1. QIAGEN
- 17.1.1. Corporate Summary
- 17.1.2. Corporate Financial Review
- 17.1.3. Product Portfolio
- 17.1.4. Key Development
- 17.2. Agilent Technologies, Inc
- 17.3. Thermo Fisher Scientific Inc
- 17.4. Siemens Healthineers AG
- 17.5. Danaher Corporation
- 17.6. F. Hoffmann-La Roche Ltd
- 17.7. Eppendorf SE
- 17.8. Hudson Lab Automation
- 17.9. BMG LABTECH GmbH
- 17.10. Hamilton Company
- 18. Our Research Methodology
- 18.1. Our Research Practice
- 18.2. Data Source
- 18.2.1. Secondary Source
- 18.2.2. Primary Source
- 18.3. Data Assumption
- 18.4. Analytical Framework for Market Assessment and Forecasting
- 18.5. Our Research Process
- 18.6. Data Validation and Publishing (Secondary Source)
- 19. Appendix
- 19.1. Disclaimer
- 19.2. Contact Us
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
